BlueLinx Q3 revenue rises 8.5%, with duty adjustments affecting EBITDA comparison

BlueLinx reported Q3 revenue of $813M, up 8.5% YoY, with adjusted EBITDA of $31.7M, a 42% increase. Growth was driven by specialty and structural building products, while import-duty adjustments affected EBITDA comparisons. The company reported a net loss of $0.6M, down from a $1.7M profit in the prior-year quarter.

Original reporting
Published Nov 6, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 7, 2026, 8:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BlueLinx Q3 revenue rises 8.5%, with duty adjustments affecting EBITDA comparison — source image
Decision brief

The 30-second read

Med
01

Why it matters

The earnings release provides fresh quantitative data on revenue growth and profitability, offering traders a basis for short‑term positioning.

02

Market read

First‑report earnings for a mid‑cap distributor; modest trading relevance for sector and the stock itself.

03

What to watch

Inventory provision of $2.9M and declining operating cash flow could signal margin pressure.

Relevance 6/10Novelty 7/10Timing: post‑market today

Background

BlueLinx is a U.S. distributor of wood panels, lumber, and engineered wood products, reporting its third‑quarter 2026 results.

Market effects

Positive signal for US building‑products distributors, may lift peers in lumber and panel space.

Limited to US construction materials market; no broader regional effect.

Low; the news is company‑specific without global macro implications.

Counterpoint

Duty adjustments inflate EBITDA; underlying operating performance may be weaker than headline suggests.

Key entities

  • BlueLinx Holdings Inc.

    U.S. building‑products distributor reporting Q3 2026 results.

Related articles

$BXCMed

What BlueLinx (BXC) Said on Its Q3 Earnings Call

BlueLinx (BXC) reported Q3 earnings, with specialty sales up 5% to $550M and structural sales up 18% to $263M. Gross margins improved in both segments. The company expanded supplier relationships and expects Q4 gross margins of 17.5-18.5% for specialty and 9-10% for structural. BlueLinx had $689M in available liquidity and $40M in free cash flow.

$BXCMed

Bluelinx Earnings Call Highlights Growth Amid Market Headwinds

Bluelinx (BXC) reported Q3 net sales of $813M (+8.5% YoY) and adjusted EBITDA of $31.7M (+42% YoY). Gross margins improved to 16.1%. Management highlighted growth in specialty and structural products, but cautioned about market headwinds like weak housing activity and rising costs. Adjusted net income rose 50% to $5.5M, but reported a net loss of $600K.

$BXCMed

BlueLinx Holdings Inc (BXC) Q3 2026 Earnings Call Highlights: Margin Expansion

BlueLinx Holdings Inc (BXC) discussed Q3 2026 earnings, highlighting margin expansion and strategic initiatives. CEO Reddy emphasized channel strategy, pricing, and cost management to mitigate seasonal and market-driven slowdowns. CFO Kelly Wall noted successful price increases and inventory investments for new supplier partnerships. Specialty volumes declined but were offset by pricing. SG&A increased due to acquisitions and higher expenses.

$BXCMed

BlueLinx (BXC) Q3 2026 Earnings Call Transcript

BlueLinx (BXC) reported Q3 2026 net sales of $813M, adjusted EBITDA of $32M (3.9% margin), and adjusted net income of $5.5M. Specialty products drove 70% of net sales and 80% of gross profit. The company expanded partnerships with key suppliers and invested in AI and digital transformation. Despite market challenges, BXC maintained strong liquidity ($689M) and plans to focus on specialty products and strategic growth.

$BXCHigh

BlueLinx Q3 2026 slides: margins expand despite soft housing market

BlueLinx Holdings (NYSE:BXC) reported Q3 2026 earnings of $0.68 per share, beating estimates, with revenue at $813 million. Despite a weak housing market, margins expanded due to pricing strategies and the Disdero acquisition. Stock rose 4.08% to $75.52. Specialty products drove 68% of sales and 78% of gross profit. The company maintains a strong balance sheet with $350 million in cash and expects market challenges to persist.